Managing sensitive information and valuable IP
As employers contemplate the grim possibility that redundancies might be unavoidable during this time of uncertainty, the rigorous governance of commercially sensitive secret information and… read more…
Tiny AI: the next big thing in intellectual property?
In this article for Compare the Cloud, we discuss the improved energy efficiency of Tiny AI, as well as the commercial benefit for companies in capitalising on the advancements they bring in giving… read more…
Higher Regional Court of Karlsruhe clarifies obligations of SEP holders and users in light of CJEU decision in Huawei v ZTE
Since the Court of Justice of the European Union (CJEU)’s decision in the case of Huawei v ZTE (July 2015) regarding competition law implications for FRAND-based standard essential patents (SEPs),… read more…
Genomics and public health: A patent attorney’s perspective
In this article for Open Access Government, Mathys & Squire partner Craig Titmus turns the spotlight on genomics and public health from a patent attorney’s perspective A genome contains the… read more…
What is Tiny AI?
In this article by IT Pro, considering what Tiny AI is, and how this emerging technology might develop, Mathys & Squire managing associate Andrew White provides his expert commentary Listed… read more…
Eureka moment? Law firms report rush to patent ideas amid UK lockdown
Mathys & Squire and two of its clients – Wootzano and Imperial College London – featured in an article written by The Guardian on the increased demand for intellectual property legal services… read more…
Enlarged Board of Appeal issues decision on plant patents
In this article by JUVE Patent, Mathys & Squire associate Alexander Robinson provides his comments regarding the Enlarged Board of Appeal ruling that plants and animals obtained from essentially… read more…
Royalty Pharma: CJEU answers SPC questions – and raises new ones
On 30 April 2020, the Court of Justice of the EU (CJEU) handed down the latest in a long line of decisions regarding the question of how precisely a product must be identified in a patent in order… read more…
New Rules of Procedure in EPO appeals – early case law suggests remittal will remain common
The EPO’s new Rules of Procedure of the Boards of Appeal (RPBA) came into force on 1 January 2020 One notable change was to Article 11 RPBA, which concerns when a Board of Appeal should remit a… read more…
